Advertisement

Topics

Akebia to Host Conference Call on March 6th to Discuss Full-Year 2016 Financial Results and Corporate Highlights

08:30 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced that the Comp...

Other Sources for this Article

Akebia Therapeutics, Inc.
Theresa McNeely, 617-844-6113
SVP, Corporate Communications and Investor Relations
Tmcneely@akebia.com

NEXT ARTICLE

More From BioPortfolio on "Akebia to Host Conference Call on March 6th to Discuss Full-Year 2016 Financial Results and Corporate Highlights"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...